OncoPan^®: An NGS-Based Screening Methodology to Identify Molecular Markers for Therapy and Risk Assessment in Pancreatic Ductal Adenocarcinoma

Pancreatic cancer has a high morbidity and mortality with the majority being PC ductal adenocarcinomas (PDAC). Whole genome sequencing provides a wide description of genomic events involved in pancreatic carcinogenesis and identifies putative biomarkers for new therapeutic approaches. However, curre...

Full description

Bibliographic Details

Published in:	Biomedicines
Main Authors:	Maria Grazia Tibiletti, Ileana Carnevali, Valeria Pensotti, Anna Maria Chiaravalli, Sofia Facchi, Sara Volorio, Frederique Mariette, Paolo Mariani, Stefano Fortuzzi, Marco Alessandro Pierotti, Fausto Sessa
Format:	Article
Language:	English
Published:	MDPI AG 2022-05-01
Subjects:	pancreatic adenocarcinoma OncoPan<sup>®</sup> NGS analysis <i>HER2</i> amplification <i>HR</i> genes mutations target therapy risk assessment
Online Access:	https://www.mdpi.com/2227-9059/10/5/1208